OAC
NAGE

OMERS Administration Corp’s Niagen Bioscience NAGE Stock Holding History

OMERS Administration Corp’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,500
Closed -$107K – 1406
2025
Q3 		$107K Buy
11,500
+500
+5% +$5.05K ﹤0.01% 1045
2025
Q2 		$159K Buy
+11,000
New +$109K ﹤0.01% 796

Other funds holding NAGE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OMERS Administration Corp's NAGE Position: Q4 2025 in Review

OMERS Administration Corp sold out of Niagen Bioscience (NAGE) in Q4 2025, closing a stake of 11,500 shares — an estimated $107K sold.

OMERS Administration Corp first reported a position in NAGE in Q2 2025 and held it in 2 quarters. The position peaked at $159K in Q2 2025. 169 funds tracked by Wall St. Rank hold NAGE as of Q4 2025.

  • OMERS Administration Corp reported no remaining Niagen Bioscience position as of Q4 2025 after selling out during the quarter.
  • OMERS Administration Corp sold 11,500 Niagen Bioscience shares in Q4 2025, an estimated $107K.
  • OMERS Administration Corp first reported a position in Niagen Bioscience in Q2 2025 and held it in 2 quarters.
  • OMERS Administration Corp's Niagen Bioscience position peaked at $159K in Q2 2025.
  • 169 funds tracked by Wall St. Rank held Niagen Bioscience as of Q4 2025.

Based on OMERS Administration Corp's 13F filing for Q4 2025, filed 13 Feb 2026.